Evidence mapPaperPMID 42495375Full record

ReviewACS omega2026

Research Progress on ROS Scavenging and Responsive Materials for Biomedical Applications.

Haimang Wang, Hao Lin, Baoxuan Wei, Shunxian Gong, Jingxun Lu, Yingying Fan, Jinghua Li, Yi Wang

Abstract readReview
In one paragraph

Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Haimang WangCollege of Chemical Engineering, Ordos Institute of Technology, Ordos 017000, China.
Hao LinCollege of Mechanical & Energy Engineering, Beijing University of Technology, Beijing 100124, China.
Baoxuan WeiCollege of Mechanical & Energy Engineering, Beijing University of Technology, Beijing 100124, China.
Shunxian GongCollege of Mechanical & Energy Engineering, Beijing University of Technology, Beijing 100124, China.
Jingxun LuCollege of Mechanical & Energy Engineering, Beijing University of Technology, Beijing 100124, China.
Yingying FanCollege of Chemical Engineering, Ordos Institute of Technology, Ordos 017000, China.
Jinghua LiDepartment of Hepatobiliary Surgery, Affiliated Hospital of Hebei University, Baoding 071000, China.
Yi WangCollege of Mechanical & Energy Engineering, Beijing University of Technology, Beijing 100124, China.ORCID https://orcid.org/0000-0003-2455-2988

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reactive oxygen species (ROS) participate in essential physiological processes such as cellular signaling under normal conditions; however, their excessive accumulation under oxidative stress can induce various diseases. Addressing this challenge, the development of biomaterials capable of precisely regulating ROS levels is of great significance. This review systematically summarizes two classes of biomaterials for modulating oxidative stressROS-scavenging materials and ROS-responsive materialsfrom the perspective of material design principles, elucidating their underlying mechanisms and construction strategies, respectively. ROS-scavenging materials primarily include nanozymes, inorganic nanoparticles, natural antioxidants, and polymers rich in reactive functional groups, which exert antioxidant effects through sustained consumption of excess ROS. In contrast, ROS-responsive materials exploit responsive moieties such as phenylboronic esters, thioketals and diselenides to trigger structural disassembly or drug release within high-ROS microenvironments, thereby enabling spatiotemporally controlled on-demand delivery. Furthermore, this review also discusses the synergistic therapeutic potential of multiresponsive materials. Finally, the major challenges currently facing this field are summarized, and future directions for clinical translation are prospected.

Identifiers

PMID42495375
PMCPMC13393025

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.